Pulse Biosciences Announces Treatment of First Patients in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation for Treatment of Sebaceous Hyperplasia Lesions
In a media release, Pulse Biosciences Inc announces treatment of the first patients in its multi-center study to evaluate the safety and efficacy of its Nano-Pulse Stimulation (NPS) technology for eliminating Sebaceous Hyperplasia (SH).
